|
시장보고서
상품코드
1762248
바이오마커 탐색 아웃소싱 서비스 시장 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 치료 분야별, 탐색 단계별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Discovery Phase, End Use, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 바이오마커 탐색 아웃소싱 서비스 세계 시장 규모는 2034년까지 839억 3,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
바이오마커 탐색 아웃소싱 서비스는 질병 진단, 의약품 개발, 맞춤의료에 중요한 역할을 하는 바이오마커의 식별, 검증, 개발을 제3의 기관과 계약하여 수행하는 서비스입니다. 이러한 서비스는 의약품 개발 업무 위탁기관(CRO), 생명공학 기업, 전문 연구소가 제공하며, 제약기업과 헬스케어 기업은 차세대 염기서열 분석, 단백질체학, 바이오인포매틱스 등 첨단 기술을 활용할 수 있습니다. 바이오마커 발굴을 아웃소싱함으로써 기업은 연구개발(R&D)의 효율성을 최적화하고, 운영 비용을 절감하며, 새로운 치료법의 시장 출시 시간을 단축할 수 있습니다. 정밀의료와 표적치료에 대한 관심이 높아짐에 따라 바이오마커는 환자별 치료 반응을 파악하고 임상시험의 성공률을 높이는 데 도움이 되기 때문에 이러한 서비스에 대한 수요가 크게 증가하고 있습니다. 바이오마커 탐색 아웃소싱 서비스 시장은 연구 협력의 증가, 헬스케어 투자 증가, 바이오마커 기반 진단의 발전으로 인해 꾸준한 성장세를 보이고 있습니다.
바이오마커 탐색 아웃소싱 서비스 시장은 기술 발전, 탄탄한 제약 부문, 우호적인 규제 프레임워크에 힘입어 크게 성장하고 있습니다. 주요 촉진요인으로는 바이오마커 분석을 강화하기 위한 인공지능(AI)과 머신러닝의 채택 증가, 다양한 연구 수요를 충족시키기 위한 서비스 포트폴리오의 확대 등이 있습니다. 또한, 개발사들은 효율성과 경쟁력을 향상시키기 위해 제약사들과의 전략적 제휴를 우선순위에 두고 있습니다. 맞춤형 의료와 바이오마커 기반 의약품 개발에 대한 관심이 높아지면서 시장 개척이 가속화되고 있으며, 질병 탐지 및 치료 최적화를 위한 혁신적인 솔루션에 대한 기회가 창출되고 있습니다. 정밀의료에 대한 수요가 증가함에 따라 생물의학 연구와 치료법 개발을 발전시키는 최첨단 도구와 서비스를 제공하는 시장은 지속적으로 발전할 준비가 되어 있습니다.
바이오마커 탐색 아웃소싱 서비스 시장 보고서 하이라이트
유형별로는 대리 평가지표가 가장 큰 시장 점유율을 차지하고 있습니다. 대리 평가변수는 임상 결과를 나타내는 간접적인 지표로 작용하여 연구자들이 의약품 개발 과정에서 치료의 효과와 안전성을 보다 효율적으로 평가할 수 있도록 돕습니다.
치료 분야별로 보면 암 분야가 바이오마커 탐색 아웃소싱 서비스 시장을 주도하고 있습니다. 이는 암 발병률의 증가와 바이오마커 기반 의약품 개발의 채택 확대에 기인합니다. 암의 조기 발견, 예후 예측, 치료법 선택에 있어 바이오마커의 활용이 임상연구에서 이 분야의 중요성을 높이고 있습니다.
북미가 가장 큰 시장 점유율을 차지하고 있습니다. 이러한 우위성은 높은 R&D 투자, 정밀의료의 중요성, 제약기업과 CRO(임상시험수탁기관)의 견고한 협력관계에 기인합니다.
바이오마커 탐색 아웃소싱 서비스 시장의 CAGR이 가장 높은 지역은 아시아태평양입니다. 이러한 급속한 성장은 제약 기업의 R&D 활동 증가, 임상시험 업무의 급증, 중국 및 인도와 같은 국가에서 이용할 수 있는 비용 효율적인 아웃소싱 솔루션에 기인합니다.
바이오마커 탐색 아웃소싱 서비스 시장의 주요 기업으로는 Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, Fujirebio Holdings Inc 등이 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계 바이오마커 탐색 아웃소싱 서비스 시장 인사이트
- 시장 현황
- 바이오마커 탐색 아웃소싱 서비스 시장 역학
- 성장 촉진요인과 기회
- 만성질환 유병률 상승
- 오믹스 기술의 진보
- 성장 억제요인과 과제
- 바이오마커 검증의 고비용과 복잡성
- 성장 촉진요인과 기회
- PESTEL 분석
- 바이오마커 탐색 아웃소싱 서비스 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 바이오마커 탐색 아웃소싱 서비스 시장 : 유형별
- 주요 조사 결과
- 소개
- 예측 바이오마커
- 예후 바이오마커
- 안전성 바이오마커
- 대체 엔드포인트
제6장 세계의 바이오마커 탐색 아웃소싱 서비스 시장 : 치료 분야별
- 주요 조사 결과
- 소개
- 종양학
- 신경학
- 심장병학
- 자가면역질환
- 기타
제7장 세계의 바이오마커 탐색 아웃소싱 서비스 시장 : 탐색 단계별
- 주요 조사 결과
- 소개
- 바이오마커 동정
- 바이오마커 검증
- 바이오마커 프로파일링
- 바이오마커 패널 개발
- 바이오마커 선택
제8장 세계의 바이오마커 탐색 아웃소싱 서비스 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 제약회사
- 바이오테크놀러지 기업
- 기타
제9장 세계의 바이오마커 탐색 아웃소싱 서비스 시장 : 지역
- 주요 조사 결과
- 소개
- 바이오마커 탐색 아웃소싱 서비스 시장 평가 : 지역, 2020-2034년
- 북미
- 북미 : 유형별, 2020-2034년
- 북미 : 치료 분야별, 2020-2034년
- 북미 : 발견 단계별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 치료 분야별, 2020-2034년
- 유럽 : 발견 단계별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 치료 분야별, 2020-2034년
- 아시아태평양 : 발견 단계별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 치료 분야별, 2020-2034년
- 중동 및 아프리카 : 발견 단계별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 치료 분야별, 2020-2034년
- 라틴아메리카 : 발견 단계별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- Celerion
- Charles River Laboratories International, Inc.
- Eurofins Scientific
- Evotec
- Fujirebio Holdings Inc.
- GenScript ProBio
- ICON plc
- Laboratory Corporation of America Holdings(Labcorp)
- Parexel International(MA) Corporation
- Proteome Sciences
- Thermo Fisher Scientific Inc.
- WuXi AppTec
The global biomarker discovery outsourcing services market size is expected to reach USD 83.93 billion by 2034, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, and Surrogate Endpoints), Therapeutic Area, Discovery Phase, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Biomarker discovery outsourcing services involve contracting third-party organizations to identify, validate, and develop biomarkers that play a crucial role in disease diagnosis, drug development, and personalized medicine. These services are offered by contract research organizations (CROs), biotechnology firms, and specialized laboratories, providing pharmaceutical and healthcare companies access to advanced technologies such as next-generation sequencing, proteomics, and bioinformatics. By outsourcing biomarker discovery, companies can optimize research and development (R&D) efficiency, reduce operational costs, and accelerate the time-to-market for new therapies. The growing focus on precision medicine and targeted therapies has significantly increased the demand for these services, as biomarkers help in identifying patient-specific responses to treatments and improving clinical trial success rates. The biomarker discovery outsourcing services market is witnessing steady growth due to increasing research collaborations, rising healthcare investments, and advancements in biomarker-based diagnostics.
The biomarker discovery outsourcing services market is experiencing significant growth, fueled by advancements in technology, a robust pharmaceutical sector, and supportive regulatory frameworks. Key drivers include the increasing adoption of artificial intelligence (AI) and machine learning to enhance biomarker analysis, as well as the expansion of service portfolios to meet diverse research needs. Companies are also prioritizing strategic collaborations with drug developers to improve efficiency and competitiveness. The rising focus on personalized medicine and biomarker-driven drug development is further accelerating market expansion, creating opportunities for innovative solutions in disease detection and treatment optimization. As demand for precision medicine grows, the market is poised for continued progress, offering cutting-edge tools and services to advance biomedical research and therapeutic development.
Biomarker Discovery Outsourcing Services Market Report Highlights
By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.
By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.
North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).
Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.
The biomarker discovery outsourcing services market key players include Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, and Fujirebio Holdings Inc
Polaris Market Research has segmented biomarker discovery outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:
By Type Outlook (Revenue-USD Billion, 2020-2034)
Predictive Biomarkers
Prognostic Biomarkers
Safety Biomarkers
Surrogate Endpoints
By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)
Oncology
Neurology
Cardiology
Autoimmune Diseases
Others
By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)
Biomarker Identification
Biomarker Validation
Biomarker Profiling
Biomarker Panel Development
Biomarker Selection
By End Use Outlook (Revenue-USD Billion, 2020-2034)
Pharmaceutical Companies
Biotechnology Companies
Others
By Regional Outlook (Revenue-USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
Suth Korea
Indnesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
Suth Africa
Rest of Middle East & Africa
Latin America
Mexic
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Biomarker Discovery Outsourcing Services Market Insights
- 4.1. Biomarker Discovery Outsourcing Services Market - Market Snapshot
- 4.2. Biomarker Discovery Outsourcing Services Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Chronic Diseases
- 4.2.1.2. Advancements in Omics Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost and complexity of biomarker validation
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Biomarker Discovery Outsourcing Services Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Biomarker Discovery Outsourcing Services Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 5.3. Predictive biomarkers
- 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2020-2034 (USD Billion)
- 5.4. Prognostic biomarkers
- 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2020-2034 (USD Billion)
- 5.5. Safety biomarkers
- 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2020-2034 (USD Billion)
- 5.6. Surrogate endpoints
- 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2020-2034 (USD Billion)
6. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 6.3. Oncology
- 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 6.4. Neurology
- 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2020-2034 (USD Billion)
- 6.5. Cardiology
- 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2020-2034 (USD Billion)
- 6.6. Autoimmune Diseases
- 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
- 6.7. Others
- 6.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 7.3. Biomarker Identification
- 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2020-2034 (USD Billion)
- 7.4. Biomarker Validation
- 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2020-2034 (USD Billion)
- 7.5. Biomarker Profiling
- 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2020-2034 (USD Billion)
- 7.6. Biomarker Panel Development
- 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2020-2034 (USD Billion)
- 7.7. Biomarker Selection
- 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2020-2034 (USD Billion)
8. Global Biomarker Discovery Outsourcing Services Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 8.3. Pharmaceutical Companies
- 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 8.4. Biotechnology Companies
- 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2020-2034 (USD Billion)
- 8.5. Others
- 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)
9. Global Biomarker Discovery Outsourcing Services Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Biomarker Discovery Outsourcing Services Market - North America
- 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5. Biomarker Discovery Outsourcing Services Market - US
- 9.3.5.1. US: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.3.5.2. US: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.3.5.3. US: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.3.5.4. US: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
- 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4. Biomarker Discovery Outsourcing Services Market - Europe
- 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
- 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6. Biomarker Discovery Outsourcing Services Market - France
- 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
- 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
- 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
- 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
- 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
- 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12. Biomarker Discovery Outsourcing Services Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
- 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5. Biomarker Discovery Outsourcing Services Market - China
- 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.5.2. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6. Biomarker Discovery Outsourcing Services Market - India
- 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.6.2. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7. Biomarker Discovery Outsourcing Services Market - Malaysia
- 9.5.7.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8. Biomarker Discovery Outsourcing Services Market - Japan
- 9.5.8.1. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
- 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
- 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11. Biomarker Discovery Outsourcing Services Market - Australia
- 9.5.11.1. Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12. Biomarker Discovery Outsourcing Services Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6. Biomarker Discovery Outsourcing Services Market - UAE
- 9.6.6.1. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
- 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8. Biomarker Discovery Outsourcing Services Market - South Africa
- 9.6.8.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9. Biomarker Discovery Outsourcing Services Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7. Biomarker Discovery Outsourcing Services Market - Latin America
- 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
- 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
- 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
- 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8. Biomarker Discovery Outsourcing Services Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Celerion
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Charles River Laboratories International, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Eurofins Scientific
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Evotec
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Fujirebio Holdings Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. GenScript ProBio
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. ICON plc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Laboratory Corporation of America Holdings (Labcorp)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Parexel International (MA) Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Proteome Sciences
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Thermo Fisher Scientific Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. WuXi AppTec
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
